JP2010507780A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010507780A5 JP2010507780A5 JP2009533290A JP2009533290A JP2010507780A5 JP 2010507780 A5 JP2010507780 A5 JP 2010507780A5 JP 2009533290 A JP2009533290 A JP 2009533290A JP 2009533290 A JP2009533290 A JP 2009533290A JP 2010507780 A5 JP2010507780 A5 JP 2010507780A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- virus
- protein
- agent
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 14
- 239000003795 chemical substances by application Substances 0.000 claims 11
- 241000713196 Influenza B virus Species 0.000 claims 10
- 239000013610 patient sample Substances 0.000 claims 5
- 208000037798 influenza B Diseases 0.000 claims 3
- 239000000523 sample Substances 0.000 claims 3
- 241000712431 Influenza A virus Species 0.000 claims 2
- 241000713297 Influenza C virus Species 0.000 claims 2
- 108020004999 messenger RNA Proteins 0.000 claims 2
- 230000009870 specific binding Effects 0.000 claims 2
- 108050000838 Influenza A virus NS1 proteins Proteins 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000000416 exudates and transudate Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2006/041748 WO2008048276A1 (en) | 2006-10-21 | 2006-10-21 | Detection of influenza virus type b |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010507780A JP2010507780A (ja) | 2010-03-11 |
| JP2010507780A5 true JP2010507780A5 (enExample) | 2010-12-16 |
Family
ID=39314309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009533290A Withdrawn JP2010507780A (ja) | 2006-10-21 | 2006-10-21 | Ｂ型インフルエンザウイルスの検出 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20100028855A1 (enExample) |
| JP (1) | JP2010507780A (enExample) |
| WO (1) | WO2008048276A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5866291B2 (ja) * | 2010-09-30 | 2016-02-17 | 積水メディカル株式会社 | イムノクロマトグラフィー用テストストリップおよびその製造方法 |
| WO2023100825A1 (ja) | 2021-11-30 | 2023-06-08 | 富士フイルム株式会社 | 検査キット及びクロマトグラフ方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750394A (en) * | 1994-05-20 | 1998-05-12 | The Mount Sinai Medical Center | Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication |
| WO2001077394A1 (en) * | 2000-04-10 | 2001-10-18 | Mount Sinai School Of Medicine Of New York University | Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents |
| WO2002088361A2 (en) * | 2001-04-30 | 2002-11-07 | Glaxosmithkline Biologicals S.A. | Haemophilus influenzae antigens |
| US7217133B2 (en) * | 2002-04-04 | 2007-05-15 | Jeanine Thomas | Method for treating pervasive development disorder |
| CA2613482A1 (en) * | 2005-07-01 | 2007-02-15 | Arbor Vita Corporation | Methods and compositions for diagnosis and treatment of influenza |
-
2006
- 2006-10-21 US US12/298,133 patent/US20100028855A1/en not_active Abandoned
- 2006-10-21 WO PCT/US2006/041748 patent/WO2008048276A1/en not_active Ceased
- 2006-10-21 JP JP2009533290A patent/JP2010507780A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bode et al. | Borna disease virus-specific circulating immune complexes, antigenemia, and free antibodies—the key marker triplet determining infection and prevailing in severe mood disorders | |
| JP2010516678A5 (enExample) | ||
| JP2012509477A5 (enExample) | ||
| KR102351653B1 (ko) | 사스 코로나바이러스 2 스파이크 단백질과 결합하는 수용체와 항체를 포함하는 사스 코로나바이러스 2 진단 키트 | |
| NZ596409A (en) | Anti macrophage migration inhibitory factor antibodies | |
| JP2006519605A5 (enExample) | ||
| WO2007011412A3 (en) | Diagnosis and prognosis of infectious diesease clinical phenotypes and other physiologic states using host gene expresion biomarkers in blood | |
| JP2009515553A5 (enExample) | ||
| Anderson et al. | Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer | |
| JP2009524023A5 (enExample) | ||
| JP2002533680A5 (enExample) | ||
| JP2009500611A5 (enExample) | ||
| JP2015527365A5 (enExample) | ||
| ATE556717T1 (de) | Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus | |
| Batchu et al. | Lung and kidney ACE2 and TMPRSS2 in renin-angiotensin system blocker–treated comorbid diabetic mice mimicking host factors that have been linked to severe COVID-19 | |
| JP2008536480A5 (enExample) | ||
| JP2007508527A5 (enExample) | ||
| JP2013508719A5 (enExample) | ||
| JP2008530565A5 (enExample) | ||
| JP2010507780A5 (enExample) | ||
| JP2014524583A5 (enExample) | ||
| JP2012513584A5 (enExample) | ||
| JP7216949B1 (ja) | 等電点９．５以上のタンパク質の免疫測定方法及びそれに用いる検体希釈液、並びにイムノクロマトグラフィーキット | |
| JP5801895B2 (ja) | 全身性炎症反応症候群を伴わない術後感染症の検出方法 | |
| JP2008547006A5 (enExample) |